Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | Dipeptidyl peptidase 9 | 0.0315 | 0.2101 | 0.2101 |
Schistosoma mansoni | bhlhzip transcription factor bigmax | 0.0296 | 0.1838 | 0.1838 |
Echinococcus granulosus | inhibitor of apoptosis protein | 0.0566 | 0.5514 | 0.5514 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0405 | 0.3316 | 0.1538 |
Echinococcus granulosus | eukaryotic initiation factor 4A III | 0.0896 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0569 | 0.5547 | 0.5547 |
Toxoplasma gondii | kringle domain-containing protein | 0.0405 | 0.3316 | 0.2361 |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0896 | 1 | 0.5 |
Onchocerca volvulus | Eukaryotic initiation factor 4A homolog | 0.0896 | 1 | 1 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0446 | 0.3878 | 0.3878 |
Onchocerca volvulus | 0.0569 | 0.5547 | 0.5547 | |
Echinococcus multilocularis | inhibitor of apoptosis protein | 0.0566 | 0.5514 | 0.5514 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.0622 | 0.627 | 0.627 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0566 | 0.5514 | 0.5514 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0315 | 0.2101 | 0.2101 |
Echinococcus multilocularis | eukaryotic initiation factor 4A III | 0.0896 | 1 | 1 |
Echinococcus multilocularis | baculoviral IAP repeat containing protein | 0.0566 | 0.5514 | 0.5514 |
Brugia malayi | Helix-loop-helix DNA-binding domain containing protein | 0.0296 | 0.1838 | 0.1838 |
Plasmodium vivax | RNA helicase-1, putative | 0.0896 | 1 | 1 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0896 | 1 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0569 | 0.5547 | 0.5547 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0896 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0569 | 0.5547 | 0.5547 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0896 | 1 | 1 |
Schistosoma mansoni | dipeptidyl-peptidase 9 (S09 family) | 0.0315 | 0.2101 | 0.2101 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0896 | 1 | 1 |
Brugia malayi | Kringle domain containing protein | 0.0405 | 0.3316 | 0.3316 |
Loa Loa (eye worm) | helix-loop-helix DNA-binding domain-containing protein | 0.0296 | 0.1838 | 0.1838 |
Brugia malayi | hypothetical protein | 0.0193 | 0.044 | 0.044 |
Loa Loa (eye worm) | hypothetical protein | 0.0566 | 0.5514 | 0.5514 |
Onchocerca volvulus | 0.0473 | 0.4241 | 0.4241 | |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0622 | 0.627 | 0.627 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.0622 | 0.627 | 0.627 |
Schistosoma mansoni | inhibitor of apoptosis (iap) domain family member | 0.0566 | 0.5514 | 0.5514 |
Echinococcus multilocularis | max protein X | 0.0296 | 0.1838 | 0.1838 |
Loa Loa (eye worm) | hypothetical protein | 0.0193 | 0.044 | 0.044 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.0622 | 0.627 | 0.627 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0896 | 1 | 1 |
Onchocerca volvulus | 0.0566 | 0.5514 | 0.5514 | |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0896 | 1 | 0.5 |
Echinococcus granulosus | max protein X | 0.0296 | 0.1838 | 0.1838 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0896 | 1 | 1 |
Echinococcus multilocularis | eukaryotic initiation factor 4A | 0.0896 | 1 | 1 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0405 | 0.3316 | 0.3316 |
Leishmania major | hypothetical protein, conserved | 0.0405 | 0.3316 | 0.1538 |
Schistosoma mansoni | hypothetical protein | 0.0405 | 0.3316 | 0.3316 |
Echinococcus multilocularis | Dipeptidyl peptidase 9 | 0.0315 | 0.2101 | 0.2101 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0566 | 0.5514 | 0.5514 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0622 | 0.627 | 0.627 |
Echinococcus granulosus | baculoviral IAP repeat containing protein | 0.0566 | 0.5514 | 0.5514 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0896 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0566 | 0.5514 | 0.5514 |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0896 | 1 | 1 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0896 | 1 | 1 |
Echinococcus granulosus | eukaryotic initiation factor 4A | 0.0896 | 1 | 1 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0896 | 1 | 0.5 |
Schistosoma mansoni | inhibitor of apoptosis protein | 0.0566 | 0.5514 | 0.5514 |
Brugia malayi | Protein kinase domain containing protein | 0.0446 | 0.3878 | 0.3878 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0405 | 0.3316 | 0.3316 |
Treponema pallidum | ATP-dependent RNA helicase | 0.0896 | 1 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0896 | 1 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0569 | 0.5547 | 0.5547 |
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0896 | 1 | 1 |
Onchocerca volvulus | Deterin homolog | 0.0566 | 0.5514 | 0.5514 |
Schistosoma mansoni | bhlhzip transcription factor bigmax | 0.0296 | 0.1838 | 0.1838 |
Loa Loa (eye worm) | hypothetical protein | 0.0405 | 0.3316 | 0.3316 |
Loa Loa (eye worm) | hypothetical protein | 0.0896 | 1 | 1 |
Onchocerca volvulus | 0.0405 | 0.3316 | 0.3316 | |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.0622 | 0.627 | 0.627 |
Schistosoma mansoni | hypothetical protein | 0.0566 | 0.5514 | 0.5514 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0896 | 1 | 1 |
Brugia malayi | Trypsin family protein | 0.0569 | 0.5547 | 0.5547 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.